Literature DB >> 2659900

Production of human tumor necrosis factor from whole blood ex vivo.

C E Desch1, N L Kovach, W Present, C Broyles, J M Harlan.   

Abstract

Since monocytes are the major source of tumor necrosis factor-alpha (TNF) in whole blood, we have developed a new method for stimulating TNF production using heparinized human whole blood instead of isolated monocytes. Test agents were dissolved in endotoxin-free buffer and 25 microliters aliquots were added directly to 225 microliters of whole blood. Following incubation at 37 degrees C, TNF levels were measured directly from diluted plasma (10%) by enzyme-linked immunoassay or L929 bioassay. Unstimulated whole blood released no detectable TNF (less than 150 pg/ml; less than 40 U/ml) over a 24 hour incubation period, but significant TNF release could be detected following a 6 hour incubation with 10 ng/ml of LPS (2163 pg/ml; 390 +/- 240 U/ml). In contrast to methods using isolated monocytes, the measurement of TNF production in whole blood ex vivo avoids monocyte activation by an adherence step, reduces the risk of contamination by endotoxin during isolation, and eliminates potentially confounding exogenous serum factors. More importantly, this method examines monocyte TNF release in response to stimuli in the relevant physiologic milieu.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2659900

Source DB:  PubMed          Journal:  Lymphokine Res        ISSN: 0277-6766


  20 in total

1.  Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages.

Authors:  J C Mathison; G D Virca; E Wolfson; P S Tobias; K Glaser; R J Ulevitch
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

2.  Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans.

Authors:  H Bruunsgaard; A N Pedersen; M Schroll; P Skinhoj; B K Pedersen
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

3.  Differential induction of pro- and anti-inflammatory cytokines in whole blood by bacteria: effects of antibiotic treatment.

Authors:  J T Frieling; J A Mulder; T Hendriks; J H Curfs; C J van der Linden; R W Sauerwein
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

4.  The effects of antiinflammatory and antiallergic drugs on cytokine release after stimulation of human whole blood by lipopolysaccharide and zymosan A.

Authors:  D A Hartman; S J Ochalski; R P Carlson
Journal:  Inflamm Res       Date:  1995-07       Impact factor: 4.575

5.  Butyrate strongly inhibits in vitro stimulated release of cytokines in blood.

Authors:  Stéphane Nancey; Jacques Bienvenu; Benoît Coffin; Françoise Andre; Louis Descos; Bernard Flourié
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

6.  Aberrant TNF secretion by whole blood in healthy subjects with a history of reactive arthritis: time course in adherent and non-adherent cultures.

Authors:  K Anttonen; A Orpana; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

7.  Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood.

Authors:  L E DeForge; J C Fantone; J S Kenney; D G Remick
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

8.  Cytokine production in whole blood ex vivo.

Authors:  M B Finch-Arietta; F R Cochran
Journal:  Agents Actions       Date:  1991-09

9.  Prolonged expression of lipopolysaccharide (LPS)-induced inflammatory genes in whole blood requires continual exposure to LPS.

Authors:  R L Dedrick; P J Conlon
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

10.  Interleukin-1 receptor antagonist protein inhibits interleukin-8 expression in lipopolysaccharide-stimulated human whole blood.

Authors:  L E DeForge; D E Tracey; J S Kenney; D G Remick
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.